Previous work in our laboratory demonstrated that elevating SOX2 in vivo with an inducible promoter inhibited the tumor growth of PDAC cells (i-SOX2-T3M4) engineered for elevation of SOX2 [15]. The gene discussed is SOX2; the disease is neoplasm.